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Abstract Extracellular nucleotides stimulate human
neutrophils by activating the purinergic P2Y2 receptor.
However, it is not completely understood which types
of G proteins are activated downstream of this P2
receptor subtype. We investigated the G-protein cou-
pling to P2Y2 receptors and several subsequent
signaling events. Treatment of neutrophils with per-
tussis toxin (PTX), a Gi protein inhibitor, caused only
õ75% loss of nucleotide-induced Ca
2+ mobilization
indicating that nucleotides cause Ca
2+ mobilization
both through Gi-dependent and Gi-independent path-
ways. However, the PLC inhibitor U73122 almost
completely inhibited Ca
2+ mobilization in both nucle-
otide- and fMLP-stimulated neutrophils, strongly sup-
porting the view that both the PTX-sensitive and the
PTX-insensitive mechanism of Ca
2+ increase require
activation of PLC. We investigated the dependence of
ERK phosphorylation on the Gi pathway. Treatment
of neutrophils with PTX caused almost complete
inhibition of ERK phosphorylation in nucleotide or
fMLP activated neutrophils. U73122 caused inhibition
of nucleotide- or fMLP-stimulated ERK phosphoryla-
tion, suggesting that although pertussis toxin-insensi-
tive pathways cause measurable Ca
2+ mobilization,
they are not sufficient for causing ERK phosphoryla-
tion. Since PLC activation leads to intracellular Ca
2+
increase and PKC activation, we investigated if these
intracellular events are necessary for ERK phos-
phorylation. Exposure of cells to the Ca
2+ chelator
BAPTA had no effect on nucleotide- or fMLP-induced
ERK phosphorylation. However, the PKC inhibitor
GF109203X was able to almost completely inhibit
nucleotide- or fMLP-induced ERK phosphorylation.
We conclude that the P2Y2 receptor can cause Ca
2+
mobilization through a PTX-insensitive but PLC-
dependent pathway and ERK phosphorylation is
highly dependent on activation of the Gi proteins.
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Abbreviations
ERK extracellular signal-regulated kinase
fMLP formyl methionyl-leucyl-phenylalanine
GPCR G protein-coupled receptor
HBSS Hank’s balanced salt solution
MAPK mitogen-activated protein kinase
PTX pertussis toxin
ROS reactive oxygen species
Introduction
Extracellular nucleotides can induce a wide variety of
responses in many cell types, including muscle con-
traction and relaxation, vasodilation, neurotransmis-
sion, platelet aggregation, ion transport regulation, and
cell growth. In the vasculature, platelets and endothe-
lial cells release nucleotides when exposed to stimuli
such as ischemia, hypoxia, and chemical or mechanical
stress [23]. The receptors mediating these effects are
termed P2 receptors, which are activated by a variety
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receptors, which are activated by adenosine. There
are two types of P2 purinoceptors: P2Y type G
protein-coupled receptors (GPCRs), and P2X type
ligand-gated ion channels. Vascular cells have been
shown to express both the P2Y and P2X receptors [8].
The P2Y receptors possess seven transmembrane
hydrophobic domains with short extracellular amino
and intracellular carboxyl terminals that have been
linked to activation of the phosphoinositide pathway
[1, 14, 26]. The P2Y receptors are subdivided into Gq-
coupled subtypes (P2Y1, P2Y2,P 2 Y 4, P2Y6,P 2 Y 11)
and Gi-coupled subtypes (P2Y12,P 2 Y 13,P 2 Y 14). The
P2Y11 receptor additionally couples to Gs and acti-
vates adenylyl cyclase.
Early work indicated that biological responses
triggered in neutrophils by ATP and UTP are mediat-
ed by a P2Y2-like receptor, previously described as the
P2U receptor [11]. Recently, we demonstrated that, in
human neutrophils, the P2Y2 receptor mediates nucle-
otide-induced Ca
2+ mobilization, primary granule
release and extracellular signal-regulated kinase ERK
1/2 activation [19].
Conflicting reports exist regarding the coupling of
the P2Y2 receptor to heterotrimeric G proteins. Initial
evidence based on the use of pertussis toxin strongly
suggested that P2Y2 receptors are coupled to Gi pro-
teins [17, 25, 28]. However, in certain cell types, P2Y2
receptor can couple to other G proteins as well. For
example, HEL cells have been shown to express P2Y2
receptors [4]; when Ga16 is suppressed in HEL cells
using antisense RNA, Ca
2+ mobilization by UTP or
ATP was completely abrogated. This finding led to the
conclusion that stimulation of P2Y2 purinoceptors
leads to the mobilization of intracellular Ca
2+ by a
mechanism that strictly depends on Ga16, and that
P2Y2 purinoceptors can communicate with two dis-
tinct signaling pathways diverging at the G protein
level [4, 10].
We therefore investigated the G protein coupling of
the P2Y2 receptor in human neutrophils. Because
ERK 1/2 activation is essential for many neutrophil
processes such as degranulation, ROS production, and
migration [9, 20, 24, 33], we investigated the role of the
Gi protein on ERK activation.
Materials and methods
Reagents
ATP, UTP, fMLP, U73122, GF109203X, 1,2-Bis(2-
amino-5-methylphenoxy)ethane-N,N,N0,N0-tetraacetic
acid tetrakis (acetoxymethyl) ester (BAPTA), phorbol
12-myristate 13-acetate (PMA), dimethyl sulfoxide
(DMSO) and bovine serum albumin (fraction V) were
obtained from Sigma (St. Louis, Mo.). Dextran T500,
and Ficol-Paque, were from Amersham Biosciences
(Piscataway, N.J.). Fura-2 AM was from Molecular
Probes (Eugene, Ore.). Nucleotides were solubilized in
water. Stock solutions of fMLP, U73122, GF109203X,
PMA, and fura-2 AM were prepared in DMSO.
Polyclonal anti-phospho-p44/42 MAP kinase (Thr202/
Tyr204) and anti-p44/442 MAP kinase were from Cell
Signaling Technology (Beverly, Mass.). CDP-star was
from Tropix (Bedford, Mass.).
Neutrophil isolation
Venous blood was collected from healthy subjects in
polypropylene tubes containing ACD anticoagulant
(1.5% citric acid, 2.5% sodium citrate, 2% dextrose).
Blood was mixed with an equal volume of 3% dextran
T500 in saline. Erythrocytes were allowed to sediment
for 20 min, and then leukocyte rich plasma was
subjected to centrifugation on Ficol-Paque at 400  g
for 45 min. The pellet was collected and the contam-
inating erythrocytes were removed by hypotonic lysis.
Isolated neutrophils were resuspended in Hank’s
balanced salt solution (HBSS) containing bovine
serum albumin (BSA) 0.2%. Neutrophils were counted
using a Reichert-Jung hemacytometer (Hausser Scien-
tific, Horsham, Pa.). Cell viability was checked by the
Trypan blue exclusion method and was routinely found
greater than 96%.
Measurement of intracellular Ca
2+ concentration
Isolated neutrophils were incubated for 45 min at
room temperature with 1 mM Fura-2 AM (Molecular
Probes, Eugene, Ore.R). The cells were washed 3
times and then resuspended at a concentration of
3 10
6/ml in HBSS containing 0.5 mM EGTA and
BSA 0.2%. Aliquots of 0.5 ml of cells were placed in a
quartz cuvette maintained at 37-C. Intracellular calci-
um concentrations were assayed during agonist stimu-
lation using excitation wavelengths of 340 nm and 380
nm and the emission was monitored at 510 nm using an
AB2 spectrofluorometer (Spectronic Instruments,
Rochester, N.Y.). Calcium concentrations were calcu-
lated according to Tsien’s ratiometric method [16].
Western blotting
Neutrophils (6 10
6 cells/ml) were preincubated at
37-C with 2 mM CaCl2 and 1 mM MgCl2 for 10 min.
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agonist for 3 min at 37-C. The reaction was terminated
by addition of 0.5 ml of cold lysis buffer (25 mM Tris-
HCl, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100,
10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM sodium
vanadate, 0.1 mM calyculin A). Lysis was allowed to
occur for 20 min on ice. Lysates were centrifuged for 5
min at 14,000 g. Proteins from the supernatants were
separated by SDS-polyacrylamide gel electrophoresis,
transferred to polyvinylidene difluoride (PVDF) mem-
brane and incubated for 1 h in Tris buffered saline
(TBS, 20 mM Tris-HCL, 150 mM NaCl, 0.05% Tween
20, pH 7.5) containing 1% BSA. Primary antibodies
were diluted in TBS containing 1% BSA and mem-
branes were incubated overnight at 4-C in the pres-
ence of the indicated primary antibody. Membranes
were washed 3 times for 5 min at room temperature.
The appropriate secondary antibody conjugated with
alkaline phosphatase was diluted (1:5,000) in TBS
containing 1% BSA. The membranes were incubated
with the secondary antibody for 1 h at room temper-
ature. Chemiluminescent reagents were used to visu-
alize the reactive proteins on a Fuji LAS1000 digital
camera.
Measurement of neutrophil respiratory burst activity
The release of ROS was measured in aliquots of
500 ml cell suspension (3 10
6 cells /ml) which were
stimulated with agonists at 37-C in a glass cuvette
under stirring conditions. The oxidative burst was
measured using isoluminol-enhanced chemilumines-
cence in a lumi-aggregometer model 560-CA (Chro-
nolog, Havertown, Pa.). Isoluminol (10 mM) and HRP
(4 U/ml) were added. The cells were allowed to
equilibrate for 2 min before stimulation with reagents
and the luminescence signal was recorded on a chart
recorder. A standard solution of hydrogen peroxide
was used to determine the sensitivity of the peroxi-
dase-isoluminol system and for normalization of data.
Results
Characterization of the G protein coupled to P2Y
receptor in human neutrophils
To identify the role of Gi/o family of G proteins in
nucleotide-mediated intracellular Ca
2+ increase, neu-
trophils were either treated with buffer or pertussis
toxin, an inhibitor of Gi/o proteins. The cells were then
resuspended in a Ca
2+-free solution, to rule out any
contribution of Ca
2+-influx through Ca
2+ channels to
increases in intracellular calcium. As can be seen by
the fluorescence intensities in Figure 1, the response to
stimulation of neutrophils with 10 nM fMLP, 10 mM
ATP or 10 mM UTP leads to increases in intracellular
Ca
2+ concentrations. All three agonists produce similar
levels of Ca
2+ increase. Treatment with 2 mg/ml per-
tussis toxin for 2 h (Figure 1, gray tracing) abolished
the Ca
2+ increase caused by fMLP. On the other hand,
pertussis toxin-treated cells stimulated with ATP or
UTP caused a partial inhibition of the Ca
2+ responses,
both inhibited by about 70%, compared to non-treated
cells. These data indicate that the Ca
2+ increase caused
by nucleotides is partially resistant to PTX treatment,
suggesting that nucleotides may not be signaling solely
through the PTX-sensitive Gi-proteins. ROS produc-
tion was measured to check the viability of the cells
following pertussis toxin treatment (Figure 2). Even
after treatment with pertussis toxin, neutrophils stim-
ulated with 10 nM PMA are still able to produce ROS,
Figure 1 Effect of PTX on fMLP- or nucleotide-induced
intracellular Ca
2+ mobilization in isolated human neutrophils.
Isolated human neutrophils were loaded with Fura-2 and the
intracellular Ca
2+ was measured as described under Materials
and methods in a medium containing 0.5 mM EGTA. Cells were
pretreated with 2 mg/ml pertussis toxin (gray) or vehicle (black),
for 2 h and stimulated with the indicated agonists. Intracellular
Ca
2+ tracings were recorded during neutrophil stimulation with
10 nM fMLP, 10 mM ATP or 10 mM UTP. Representative
tracings for at least three independent experiments are shown
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caused by fMLP.
Role of PLC in intracellular Ca
2+ increase
in human neutrophils
PLC converts PIP2 to DAG and IP3, and IP3 leads to
Ca
2+ mobilization from intracellular stores. There are
also other candidate second messengers (i.e., NAADP-
nicotinic acid adenine dinucleotide phosphate, cyclic
ADP-ribose) that can also lead to Ca
2+ mobilization
[15]. We investigated the role of PLC in fMLP- and
nucleotide-induced Ca
2+ increase in human neutro-
phils. Incubation with the PLC inhibitor U73122
abolished fMLP- or nucleotide-induced intracellular
Ca
2+ increase (Figure 3). These results indicate that
both the PTX-sensitive and PTX-insensitive mecha-
nism of Ca
2+ increase require activation of PLC.
Effect of Pertussis toxin on fMLP
or nucleotide-induced ERK phosphorylation
We have previously shown that extracellular nucleo-
tides cause p44/42 (ERK) MAPK phosphorylation
and that ERK phosphorylation participates in nu-
cleotide induced-elastase release from neutrophils
[19]. Hence, we investigated the dependence of the
Gi pathway on ERK phosphorylation. PTX blocks
ERK phosphorylation caused by nucleotides or fMLP
(Figure 4). These data indicate that pertussis toxin-
Figure 2 Effect of PTX on fMLP- or PMA-induced ROS
production in isolated human neutrophils. Isolated human
neutrophils were pretreated with 2 mg/ml pertussis toxin or
vehicle for 2 h and stimulated with the indicated agonists. Cells
were incubated for 1 min with isoluminol and horseradish
peroxidase and ROS production was recorded during neutrophil
stimulation with 10 nM fMLP or 10 nM PMA, as described
under Materials and methods. Tracings representative for at
least three independent experiments are shown
Figure 4 Effect of PTX on fMLP- or nucleotide-induced ERK
phosphorylation. Isolated neutrophils were preincubated for
2 h either with 2 mg/ml pertussis toxin or vehicle. The neutrophils
were then stimulated for 3 min with 10 nM fMLP, 10 mM ATP or
10 mM UTP. Cells were lysed for 20 min on ice in the presence of
protease and phosphatase inhibitors. The samples were run on
SDS-PAGE and the proteins transferred on PVDF membranes.
The membranes were probed with an anti-phospho-ERK
antibody to detect activated ERK
Figure 3 Effect of U73122 on fMLP- or nucleotide-induced
intracellular Ca
2+ increase in isolated human neutrophils.
Isolated human neutrophils were loaded with Fura-2 and
the intracellular Ca
2+ was measured as described under
Materials and methods. Intracellular Ca
2+ tracings were
obtained after pretreatment of neutrophils with 4 mM U73122
(gray)o rv e h i c l e( black)f o r2m i na t3 7 -C, followed by
stimulation with 10 nM fMLP, 10 mM ATP or 10 mM UTP.
Representative tracings for at least three independent experi-
ments are shown
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ERK phosphorylation.
Role of the PLC-Ca
2+ pathway
on ERK phosphorylation
An important step in intracellular Ca
2+ increases is
activation of PLC. To investigate whether PLC acti-
vation was essential for phosphorylation of ERK by
neutrophils, the cells were either preincubated with 4
mM of the PLC specific inhibitor, U73122, or vehicle
before being activated with 10 mM nucleotides or 10
nM fMLP. After 3 min neutrophils were lysed and
assayed for ERK activation. These data indicate that
that both fMLP- and nucleotide-mediated ERK phos-
phorylation requires PLC activation (Figure 5).
We investigated whether Ca
2+ release from internal
stores is required for ERK activation. Neutrophils
were preincubated with 20 mM of BAPTA/AM, an
intracellular calcium chelator, or vehicle for 15 min at
37-C prior to activation. ERK activation induced by 10
mM nucleotides or 10 nM fMLP was not inhibited by
treatment with BAPTA (Figure 6). Additionally, the
ability of nucleotides to induce an increase in the
intracellular free calcium concentration was inhibited
by treatment with BAPTA (not shown), indicating that
the BAPTA treatment was effective in chelating
intracellular Ca
2+.
Effect of the PKC inhibitor GF109203X
on ERK phosphorylation
Next, we tested for the involvement of PKC on ERK
activation of nucleotide-stimulated neutrophils. To
investigate this hypothesis, neutrophils were pretreated
with 10 mM GF109203X, a pan-PKC inhibitor, or
vehicle for 2 min at 37-C. ERK phosphorylation of
neutrophils stimulated with 10 mM ATP or 10 mM UTP
for 3 min was inhibited by GF109203X (Figure 7).
GF109203X (10 mM) abolished ROS production in-
duced by fMLP (data not shown) confirming that the
inhibitor effectively blocked PKC.
Discussion
The P2Y2 receptor has been shown to be sensitive to
pertussis toxin [13], which inactivates Gi and Go
Figure 5 Effect of the PLC inhibitor U73122 on ERK phos-
phorylation. Isolated neutrophils were pretreated with 4 mM
U73122 or vehicle for 2 min and then stimulated for 3 min with
10 nM fMLP, 10 mM ATP or 10 mM UTP. Cells were lysed for 20
min on ice in the presence of protease and phosphatase
inhibitors. The samples were run on SDS-PAGE and the
proteins transferred on PVDF membranes. The membranes
were probed with an anti-phospho-ERK antibody to detect
activated ERK
Figure 6 Effect of the BAPTA on ERK phosphorylation.
Isolated neutrophils were pretreated with 20 mM BAPTA or
vehicle for 15 min at 37-C and then stimulated for 3 min with 10
nM fMLP, 10 mM ATP or 10 mM UTP. Cells were lysed for 20
min on ice in the presence of protease and phosphatase
inhibitors. The samples were run on SDS-PAGE and the
proteins transferred on PVDF membranes. The membranes
were probed with an anti-phospho-ERK antibody to detect
activated ERK
Figure 7 Effect of the PKC inhibitor GF109203X on ERK
phosphorylation. Isolated neutrophils were pretreated with 10
mM GF109203X for 2 min and then stimulated for 3 min with 10
nM fMLP, 10 mM ATP or 10 mM UTP. Cells were lysed for 20
min on ice in the presence of protease and phosphatase
inhibitors. The samples were run on SDS-PAGE and the
proteins transferred on PVDF membranes. The membranes
were probed with an anti-phospho-ERK Ab to detect activated
ERK
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the view that P2Y2 receptors can also couple to G
proteins belonging to the Gq family [4, 10]. The
coupling between P2Y2 receptors and heterotrimeric
G proteins is insufficiently described in human neu-
trophils, although nucleotides have been shown to play
important roles in modulating fundamental neutro-
phils responses, such as superoxide production [27],
chemotaxis [12, 31], adherence to endothelial cells
[22], and degranulation [19].
It is conceivable that P2Y2 couples both to Gq and
Gi proteins in a manner similar to how P2Y11 couple
to multiple G proteins [7]. Because the Gi protein can
be inactivated by pertussis toxin this provides a
valuable tool for isolating the effect of the two G
proteins. We have previously demonstrated that hu-
man neutrophils express the P2Y2 receptor, which is
responsible for both nucleotide-induced intracellular
Ca
2+ mobilization and primary granule release. The
sensitivity to PTX can aid in clarification of the G
proteins stimulated by the P2Y2 receptor. The ability
of pertussis toxin to inhibit the ATP or UTP induced
intracellular Ca
2+ mobilization indicates that the Gi/o
family of proteins plays a role in increase of Ca
2+. The
inability of pertussis toxin to completely inhibit the
Ca
2+ increase is an indication that there are additional
pathways being activated. The fact that the fMLP-
induced calcium mobilization, which is known to
couple to Gi proteins, is completely inhibited by the
same treatment with pertussis toxin indicates that the
PTX treatment completely blocked the Gi proteins in
neutrophils. This is in agreement with the work in HL-
60 cells that showed fMLP receptors are completely
inhibited by treatment with pertussis toxin [30].
The Gq family proteins are known to activate PLCs
and mobilize Ca
2+ from inositol 1,4,5-trisphosphate
(IP3)-sensitive intracellular Ca
2+ stores, and are thus a
candidate for causing the observed PTX-insensitive
Ca
2+ mobilization. In particular, the a-subunit of G16
(a member of the Gq family of G proteins) has been
shown to be expressed in HL-60 cells, though this
protein is decreased when differentiated toward neu-
trophil line by treatment with DMSO [2]. Human
erythroleukemia cells expressing the P2Y2 receptor
have been shown to engage the G16 protein to
mobilize intracellular Ca
2+ [4]. Another possibility is
that the P2Y2 receptor interacts with Gq11, which has
been shown to be present on many hematopoietic cell
lines [34] and, in human embryonic kidney cells,
endogenously expressing P2Y2 nucleotide receptors
[32].
It has been well established that the activation of
PLC leads to generation of two second messengers, IP3
and DAG. IP3 induces a Ca
2+ release from the
intracellular calcium stores [29]. Intracellular Ca
2+
increases can also be the result of influx through Ca
2+
channels. For example, it has also been reported that
arachidonic acid can induce Ca
2+ mobilization from
IP3-insensitive stores [18]. In the present study, when
U73122 was used to inhibit PLC activity and thus
inhibit Ca
2+ released from IP3-sensitive stores, the
increase in intracellular Ca
2+ was abolished (Figure 3).
The fact that U73122 abolished any intracellular Ca
2+
changes indicates that the nucleotide-induced Ca
2+
mobilization in neutrophils is due to activation of PLC
(both the PTX-sensitive and PTX-insensitive pathways
require PLC activation to increase intracellular Ca
2+),
and that the PTX-insensitive pathway is not due to
Ca
2+ influx.
Previous studies have shown thatnucleotideor fMLP
stimulation of neutrophils activates ERK 1/2 [5, 19]. In
addition, stimulation of the P2Y2 receptor has been
shown in endothelial cells to activate ERK 1/2 [6]. In
this study, we show that both nucleotide- and fMLP-
induced ERK 1/2 activation in human neutrophils can
be blocked by pertussis toxin treatment. This suggests
that the signaling events activated by Gi proteins are
required for ERK 1/2 activation. The signaling of the
PTX-insensitive pathway, though sufficient to cause
activation of PLC and intracellular Ca
2+ mobilization,
does not cause ERK 1/2 phosphorylation.
Stimulation of neutrophils by nucleotides leads to
activation of PLC by PTX-sensitive and PTX-insensi-
tive pathway. Inhibition of PLC activity by U73122 did
inhibit ERK 1/2 activation; Figure 5). We have found
that concentrations of U73122 as high as 4 mM did not
change PMA-induced ROS production in neutrophils,
suggesting that neutrophil viability was not affected.
PLC inhibition has been reported in a previous study
to inhibit ERK activation by fMLP [5]. The observa-
tion that inhibition of PLC prevents intracellular Ca
2+
mobilization suggests that ERK 1/2 phosphorylation
depends on Ca
2+ mobilization or PKC activation.
Treatment of neutrophils with BAPTA, an intracellu-
lar Ca
2+ chelator, was insufficient to inhibit ERK 1/2
phosphorylation (Figure 6). This suggests that ERK
activation is mediated by an event downstream of PLC
that is not dependent on intracellular Ca
2+ increase.
P r o t e i nk i n a s eC( P K C )c o m p r i s eaf a m i l yo f
phospholipid-dependent serine-threonine kinases that
play a crucial role in signal transduction by numerous
agonists [21]. Pretreatment of neutrophils with
GF109203X (10 mM) attenuated the nucleotide-in-
duced ERK 1/2 phosphorylation (Figure 7). In prelim-
inary experiments, concentrations of GF109203X as
high as 10 mM did not alter the intracellular calcium
542 Purinergic Signalling (2006) 2:537–544increase caused by fMLP or by nucleotides, suggesting
that this reagent does not alter the viability of
granulocytes. The inhibition of ERK 1/2 phosphoryla-
tion by GF109203X suggests that PKC mediates
nucleotide-induced ERK 1/2 phosphorylation, which
is consistent with reports that PKC stimulates ERK
phosphorylation in PC12 cells [35]. Furthermore, it has
been shown that fMLP-stimulated ERK phosphoryla-
tion in rat neutrophils depends on PKC activation [5].
Also GF109203X inhibits fMLP-induced phosphoryla-
tion of ERK 1/2 in human neutrophils [3]. The concept
of multiple G protein pathways coupling to a single
receptor is not unique. The P2Y11 receptor is known to
couple to both Gq and Gs proteins [7, 10]. There are
hundreds of G protein-coupled receptors that trans-
duce signals through G proteins and the ability of a
single receptor to activate multiple G proteins pro-
vides an additional level of control of signaling path-
ways. This also leads to a difficulty in unraveling the
signaling events downstream of receptor activation.
In summary, this study brings evidence suggesting
that P2Y2 receptor activation in human neutrophils
activates multiple G proteins, both a PTX-sensitive Gi/
o class of G protein and a PTX-insensitive G protein
(outlined in Figure 8). The two G proteins lead to
activation of PLC and an increase in intracellular Ca
2+,
as well as ERK activation. The activation of ERK is
Ca
2+-independent but requires the activation of PKC.
These results may help to illuminate the signaling
events downstream of the P2Y2 receptor and the
development of therapeutic strategies to limit activa-
tion of nucleotide-induced activation of neutrophils as
a means to reduce inflammation.
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